2025. The Power of Two: Effective Management of Severe Refractory Psoriasis Through Combined TYK2 and IL-23 Inhibition. SKIN The Journal of Cutaneous Medicine. 9, 5 (Sep. 2025), 2669–2673. DOI:https://doi.org/10.25251/kj8rwg98.